Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00450177 · ClinicalTrials.gov registry record · Phase 2

Efficacy of Enteral Iron Supplementation in Critical Illness

A Phase 2 study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
Phase 2
Development phase
200
Enrollment target

NCT00450177: Completed Phase 2 study, sponsored by Weill Medical College of Cornell University.

NCT00450177 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00450177, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
Phase 2
Development phase
200 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral iron supplementation and risk of infection.

Interventions

  • DRUG Ferrous Sulfate
  • DRUG Placebo Oral Tablet

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2006-01
Est. Completion 2008-01
Phase Phase 2

What the finished NCT00450177 record still lists

NCT00450177 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher).

The record links to 0 conditions, and to 2 interventions - of which Ferrous Sulfate is the first listed.

NCT00450177 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00450177 about?

NCT00450177 is a clinical study titled "Efficacy of Enteral Iron Supplementation in Critical Illness". The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral...

What is the current status of trial NCT00450177?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2006-01. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00450177?

The interventions under investigation include: Ferrous Sulfate (DRUG), Placebo Oral Tablet (DRUG).

Who is sponsoring clinical trial NCT00450177?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00450177's enrollment target sits among peer trials

200 304th of 2000 higher than 1,652 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00450177, the US trial registry maintained by the National Library of Medicine. NCT00450177 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.